The complications surrounding vector-borne diseases have ever remained confusing even for medical practitioners. But technology makes almost everything simple and with what a Parasitologist ...
Convidecia is under clinical development by CanSino Biologics and currently in Phase III for Coronavirus Disease 2019 (COVID-19).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback